A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3.

Erickson, Stephen W; Stephens, Owen W; Chavan, Shweta S; Epstein, Joshua; Barlogie, Bart; Heuck, Christoph J; Vangsted, Annette J

Erickson, Stephen W; Stephens, Owen W; Chavan, Shweta S; Epstein, Joshua; Barlogie, Bart; Heuck, Christoph J; Vangsted, Annette J.

Affiliation

Erickson SW; RTI International, Research Triangle Park, Durham, NC, USA.
Stephens OW; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Chavan SS; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Epstein J; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Barlogie B; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Heuck CJ; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Vangsted AJ; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Annette.juul.vangsted@regionh.dk.

Br J Haematol ; 174(6): 991-3, 2016 09.

Article de En | MEDLINE | ID: mdl-26568154

Sujet(s)
Mots clés

genetic variants; myeloma; outcome

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Variation génétique / Protéines et peptides de signalisation intracellulaire / Myélome multiple Type d'étude: Clinical_trials / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Br J Haematol Année: 2016 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google